Boldly transforming the lives of individuals with rare neurological diseases
Science-driven and patient-focused, our mission is to bring treatments to individuals with rare neurological diseases who have little or no treatment options.
Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for rare neurological diseases.
At Ovid, we seek to understand what matters most to individuals with rare diseases and their families. We are committed to address the challenges they face every day.
- Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer
- Ovid Therapeutics Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board
- Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
- Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference